Inhibition of fludarabine metabolism by arabinosylcytosine during therapy
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 31 (3) , 193-199
- https://doi.org/10.1007/bf00685547
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- Human deoxycytidine kinase: kinetic mechanism and end-product regulationBiochemistry, 1989
- 9-?-D-Arabinofuranosyl-2-fluoroadenine 5?-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphomaCancer Chemotherapy and Pharmacology, 1986
- Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaThe American Journal of Medicine, 1986
- Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.Proceedings of the National Academy of Sciences, 1984
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJournal of Clinical Investigation, 1982
- Determination of cytarabine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- ESTRIP, a BASIC Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1978
- Human deoxycytidine kinase purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patientsBiochimica et Biophysica Acta (BBA) - Enzymology, 1977
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967